Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blackbox Bio is a private life-science tools company developing automated in vivo behavioral analysis systems for preclinical research. Its products combine hardware, sensing, and machine-learning software to quantify rodent gait, posture, weight bearing, and other behaviors in a high-throughput and reproducible manner. The company markets the Blackbox One and Blackbox Two platforms together with its palmReader analytics software to support animal-model studies in pain, orthopedics, neuroscience, neurodegeneration, muscle disorders, and spinal cord injury. Rather than developing therapeutics, Blackbox Bio provides enabling research technology intended to improve preclinical phenotyping and translational decision-making for drug discovery and academic laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Black Box.